GeoVax director receives 6,000 stock options
GeoVax Labs, Inc. director Morgan Jayne received a grant of stock options covering 6,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
GeoVax Labs, Inc. director Morgan Jayne received a grant of stock options covering 6,000 shares of common stock. The options have an exercise price of $1.18 per share, become exercisable on June 17, 2027, and are scheduled to expire on June 17, 2036. This is a compensation-related award reported as an acquisition of derivative securities, not an open-market purchase or sale of common stock.
Insider Trade Summary
Grant/Award: 6,000 shares
Grant/Award
1 txn
Insider
Morgan Jayne
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 6,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 6,000 contracts (Direct)
Key Figures
Options granted: 6,000 options
Exercise price: $1.18 per share
Options exercisable date: June 17, 2027
+2 more
5 metrics
Options granted
6,000 options
Stock option grant to director Morgan Jayne
Exercise price
$1.18 per share
Exercise price of stock options
Options exercisable date
June 17, 2027
Date options become exercisable
Options expiration date
June 17, 2036
Expiration of stock options
Total options after grant
6,000 options
Holdings following transaction
Key Terms
Stock Option, Common Stock, Grant, award, or other acquisition, derivative securities
4 terms
Stock Option financial
"security_title: "Stock Option""
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
derivative securities financial
"The options are a compensation-related award reported as an acquisition of derivative securities"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did GeoVax (GOVX) report for Morgan Jayne?
GeoVax reported that director Morgan Jayne received a grant of stock options for 6,000 shares of common stock. The options are a compensation-related award, not an open-market trade, and were reported on a Form 4 insider transaction filing.
What is the exercise price of Morgan Jayne’s new GeoVax (GOVX) stock options?
The new stock options granted to Morgan Jayne have an exercise price of $1.18 per share. This means Jayne can buy GeoVax common stock at $1.18 once the options become exercisable, regardless of the market price at that time.
When do Morgan Jayne’s GeoVax (GOVX) stock options vest and expire?
Morgan Jayne’s 6,000 GeoVax stock options become exercisable on June 17, 2027 and are scheduled to expire on June 17, 2036. After the expiration date, any unexercised options will no longer be usable.
Did Morgan Jayne buy or sell GeoVax (GOVX) common stock in this Form 4?
No, the Form 4 reports a grant of stock options, not an open-market buy or sell of common stock. The transaction is classified as an acquisition of derivative securities through a grant or award, with no reported market purchase or sale.
How many GeoVax (GOVX) options does Morgan Jayne hold after this grant?
Following the reported transaction, Morgan Jayne holds 6,000 stock options as shown in the filing. These options each relate to one share of GeoVax common stock and represent the total derivative position visible in this specific Form 4.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates